We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$248M
AUM Growth
-$54.7M
Cap. Flow
-$53.1M
Cap. Flow %
-21.45%
Top 10 Hldgs %
14.37%
Holding
315
New
136
Increased
18
Reduced
93
Closed
58

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$3.08M
2
URI icon
United Rentals
URI
+$3.05M
3
HDS
HD Supply Holdings, Inc.
HDS
+$2.72M
4
XYZ
Block Inc
XYZ
+$2.61M
5
SBAC icon
SBA Communications
SBAC
+$2.46M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$5.27M
2
NXPI icon
NXP Semiconductors
NXPI
+$4.94M
3
ACHN
Achillion Pharmaceuticals
ACHN
+$4.67M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$4.24M
5
ARMK icon
Aramark
ARMK
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 24.81%
2 Technology 18.88%
3 Industrials 12.19%
4 Consumer Discretionary 11.96%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
276
VanEck Gold Miners ETF
GDX
$25.6B
– –
-41,110
Closed -$1.09M
HRTX icon
277
Heron Therapeutics
HRTX
$94.5M
– –
-45,390
Closed -$782K
JACK icon
278
Jack in the Box
JACK
$331M
– –
-20,500
Closed -$1.97M
LLY icon
279
Eli Lilly
LLY
$1.06T
– –
-300
Closed -$24K
MCHP icon
280
Microchip Technology
MCHP
$40.4B
– –
-24,000
Closed -$746K
MSCI icon
281
MSCI
MSCI
$41.2B
– –
-18,500
Closed -$1.55M
MYGN icon
282
Myriad Genetics
MYGN
$304M
– –
-24,790
Closed -$510K
NBIX icon
283
Neurocrine Biosciences
NBIX
$16.2B
– –
-44,430
Closed -$2.25M
NVS icon
284
Novartis
NVS
$293B
– –
-893
Closed -$63K
OMCL icon
285
Omnicell
OMCL
$1.65B
– –
-16,000
Closed -$613K
OXM icon
286
Oxford Industries
OXM
$560M
– –
-6,000
Closed -$406K
PPG icon
287
PPG Industries
PPG
$26B
– –
-28,660
Closed -$2.96M
QLYS icon
288
Qualys
QLYS
$6.29B
– –
-44,000
Closed -$1.68M
RH icon
289
RH
RH
$3.56B
– –
-15,000
Closed -$519K
STZ icon
290
Constellation Brands
STZ
$22.6B
– –
-22,190
Closed -$3.69M
SUPN icon
291
Supernus Pharmaceuticals
SUPN
$2.72B
– –
-28,000
Closed -$692K
TEVA icon
292
Teva Pharmaceuticals
TEVA
$40.6B
– –
-15,400
Closed -$709K
THO icon
293
Thor Industries
THO
$4.04B
– –
-21,500
Closed -$1.82M
TYL icon
294
Tyler Technologies
TYL
$12.5B
– –
-1,700
Closed -$291K
UI icon
295
Ubiquiti
UI
$34.3B
– –
-22,000
Closed -$1.18M
WAT icon
296
Waters Corp
WAT
$39.2B
– –
-5,190
Closed -$823K
WSO icon
297
Watsco Inc
WSO
$13.2B
– –
-1,750
Closed -$247K
XOP icon
298
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.52B
– –
-3,878
Closed -$597K
OIG
299
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
– –
-5,099
Closed -$1.19M
AUY
300
DELISTED
Yamana Gold, Inc.
AUY
– –
-82,550
Closed -$356K
9 10 11
12
13

Similar funds

IP
InvenTrust Properties Downers Grove, Illinois $1.08M AUM 0.39% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PAM
Prudence Asset Management Hong Kong $3.65M AUM 36.79% 1-Year Est. Return
CCM
Catalus Capital Management Greenwich, Connecticut $6.09M AUM 3.76% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
LRM
Lime Rock Management Westport, Connecticut $7.54M AUM 22.09% 1-Year Est. Return
HC
Highstar Capital New York $8.59M AUM 3.82% 1-Year Est. Return

Turner Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Turner Investments held 315 positions worth $248M, down 18% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Turner Investments withdrew a net $53.1M in Q4 2016, closing 58 positions and reducing 93 holdings. Its most notable exit was Aramark, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Idexx Laboratories worth $3.17M.

  • Turner Investments's largest Q4 2016 buy was Idexx Laboratories: 27,000 shares worth $3.17M.
  • Turner Investments added most to bluebird bio in Q4 2016, an estimated $1.26M increase.
  • Turner Investments's biggest Q4 2016 reduction was Paramount Global Class B, cutting an estimated $5.27M.
  • Turner Investments fully exited Aramark in Q4 2016, selling an estimated $4.09M.
  • Turner Investments's ten largest holdings make up 14% of its $248M portfolio in Q4 2016.
  • Turner Investments opened 136 new positions and closed 58 in Q4 2016.
  • Turner Investments's portfolio value fell 18% quarter-over-quarter to $248M.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.